Venous thromboembolism, though rare in the community, is a major cause of death among hospitalized patients. It is estimated to cause 100,000 deaths per year and to contribute to mortality in another ...

ORLANDO, Fla. — Patients who underwent hip fracture surgery and were prescribed deep vein thrombosis prophylaxis for 28 days or more had a 67% lower chance of death and significantly lower ...

Functional impairment (FI) after hematopoietic cell transplantation (HCT) and impact on quality of life (QOL). Bupropion for hot flashes control in breast cancer survivors: A prospective, double-blind ...

Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the ...

Healthcare is trending toward outpatient procedures, and technological advancements in surgical technique and pain management allow orthopedic surgeons to send their patients home within 24 hours of ...

In total hip or total knee arthroplasty, hypercoagulability typically begins on the operating table and a hypercoagulable state persists for up to 3 months after surgery. For that reason, it is ...

Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Supplemental New Drug Application (sNDA) for Eliquis ...

ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis LEUVEN, Belgium and LUND, Sweden, Feb 23, 2009 (PR Newswire ...

Objective: To compare the cost effectiveness of prophylaxiswith a low-molecular-weight heparin with that of prophylaxis withunfractionated heparin for the prevention of venous thromboembolismin ...

The post-operative risk period for venous thromboembolism is still unknown and indications for post-discharge prophylaxis are controversial. Detectable thrombus formation after hip arthroplasty is ...